Rare diseases
Investigational molecules
Locations
Back to Poland232 clinical trials in Gdynia, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
PolandEfficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy
PolandA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
PolandA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
PolandA study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery
PolandStudy of tuvusertib combined with niraparib or lartesertib for patients with ovarian cancer that worsened after previous PARP inhibitor treatment
PolandPolandA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
PolandStudy on the Safety and Tolerability of VRDN-003 for Patients with Thyroid Eye Disease
PolandStudy on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory viral infections, particularly evaluating new vaccines for elderly populations. Studies target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Comprehensive research into treatments for various autoimmune disorders, including psoriatic arthritis and plaque psoriasis. Studies evaluate novel therapeutics like zasocitinib and tildrakizumab.
Innovative trials investigating treatments for heart failure prevention and cardiovascular disease. Studies examine combination therapies and novel compounds for improving cardiac outcomes.
Advanced research in breast cancer and prostate cancer treatments, focusing on metastatic disease and novel therapeutic combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
